MIR3147

Across TCGA pan-cancer cohorts, MIR3147 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR3147 data layer compared with 1 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MIR3147 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3147 expression acts as an unfavorable survival marker, although some lineages such as MESO and KIRC show a favorable association.

COAD, LUSC, and MESO are the cancer types where MIR3147 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	IV	0.028	0.496	<.001	57	view →
LUSC	OS	Tertile	II,III,IV	0.527	0.780	<.001	51	view →
MESO	OS	Tertile	III,IV	0.733	0.298	.005	48	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
LIHC	DFS	Tertile	All	0.303	0.462	.025	39	view →
BRCA	OS	Tertile	IV	0.332	0.808	.007	36	view →
UCEC	DFS	Tertile	All	0.803	0.900	.011	30	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	18	view →
LAML	DFS	Tertile	All	0.081	0.572	.005	18	view →
LUAD	OS	Tertile	III,IV	0.175	0.669	.001	18	view →
KIRC	DFS	Tertile	IV	1.000	0.312	.049	6	view →
OV	OS	Tertile	IV	1.000	0.343	.016	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR3147–COAD (DFS)

Open the COAD breakdown →